Millions Logo
home>US Stocks>InnovAge Holding
INNV
InnovAge HoldingHealthcare
$9.40+$3.98 (+73.36%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $4.7052 Week High: $12.64

InnovAge Holding Share Price Today

InnovAge Holding opened higher at $9.52, compared with its previous close of $9.50. In the last trading session, the stock traded between $9.30 and $9.58. It showed a downward intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in InnovAge Holding is now worth

$ 113.75

Giving a profit of

$ 13.75 (13.75%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 3 Analysts

Buy
33.33%
Hold
33.33%
Sell
33.33%

Markets Today

Today's Change

$-0.10 (-1.09%)

Day High

$9.58

Day Low

$9.30

Day Open

$9.52

Prev Close

$9.50

Volume

2,18,573

1W Return

-3.98%

1M Return

2.65%

3M Return

-8.07%

6M Return

27.66%

1Y Return

73.36%

Fundamentals

Market Cap ($ Mn)

1,282

PE Ratio

-

PB Ratio

6.44

PEG Ratio

-

ROE

-14.12%

ROCE

-7.91%

EPS (TTM)

$0.14

Investment Returns

1 Week

-3.98%

1 Month

2.65%

3 Months

-8.07%

6 Months

27.66%

9 Months

14.87%

Financials

Quarterly
All values in $ Mn
221.4

Jun 25
236.1

Sep 25
239.7

Dec 25
251.9

Mar 26
262.0

Jun 26
264.8

Sep 26

Updates

4Nov

InnovAge Holding Q1 FY27 adjusted EBITDA up 75% to $31.3 million

Revenue grew 12.1% YoY to $264.8 million driven by census growth and higher rates. Adjusted EBITDA surged over 75% to $31.3 million as margins expanded to 11.8%. Center-level contribution margin improved by 230 bps to 24% of revenue. Net income rose to $20.9 million from $7.7 million in the prior-year quarter. Full-year guidance reaffirmed with revenue projected at $1.05 billion to $1.085 billion.

9 days ago
23Sep

InnovAge shares fall 9% after pricing secondary offering at $9.25

Shares fell 9.43% to $9.65 in after-hours trading. Secondary offering priced at $9.25 per share. Sale involves 10 million shares by Apax and Welsh, Carson funds. Issuer receives no proceeds from the transaction.

1mo ago
9Sep

InnovAge stock jumps 10% after Q4 revenue beats estimates

Q4 revenue of $261.95 million beat analyst estimates of $238.28 million by 9.93%. Shares jumped 10.25% after-hours despite EPS missing estimates by 25%. Full-year adjusted EBITDA surged 175% YoY to $94.6 million. Center-level contribution margin expanded 500 bps to 23.0%. FY27 guidance projects revenue between $1.05 billion and $1.085 billion.

2mo ago

Similar Stocks

StockLTPChange %Market CapPE
$506.04+0.32%$1,05,708.21M14.01
$304.77-0.26%$49,345.01M45.36
$292.97+0.93%$23,316.90M10.31
$72.62+0.18%$14,450.29M52.31
$79.43-1.38%$14,087.55M-
$142.24-0.19%$13,957.16M20.21
$22.22-2.29%$11,935.03M11.93
$183.50+2.35%$11,542.15M15.26
$186.19+0.59%$10,862.51M27.11
$196.77+0.70%$10,170.65M7.00
$103.03-0.49%$8,522.13M34.79
$50.06+1.96%$7,945.72M25.00